Advertisement
Advertisement
IPHA
Innate Pharma S.A. ADS
1.73
USDSponsored
-0.05
-3.08%
Aug 07, 15:49 UTC -4
Closed
Pre-Market
2.21
+0.48
+27.51%
IPHA Earnings Reports
Positive Surprise Ratio
IPHA beat 0 of 2 last estimates.
0%
Next Report
Date of Next Report
Sep 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
$8.08M
/-$0.07
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Innate Pharma S.A. ADS earnings per share and revenue
On --, IPHA reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 8.08 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$2.09
Actual
$2.21
Surprise
+5.69%
REGENXBIO Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.05
Actual
$0.43
Surprise
+626.35%
X4 Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
SAB Biotherapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+5.15%
Cellectis S.A. - ADR
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.22
Surprise
+20.89%
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
Genmab A/S ADS
Report Date
Aug 06, 2026 For Q2 26
Estimate
$3.59
Actual
$0.54
Surprise
-84.98%
Praxis Precision Medicines, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$3.73
Actual
-$2.87
Surprise
+23.14%
Halozyme Therapeutics, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$2.27
Surprise
+21.75%
Cytokinetics Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$1.67
Actual
-$1.50
Surprise
+10.35%
FAQ
What were Innate Pharma S.A. ADS's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Innate Pharma S.A. ADS reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Innate Pharma S.A. ADS's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Innate Pharma S.A. ADS expected to report next?
The next earning report is scheduled for Sep 17, 2026.
What are the forecasts for Innate Pharma S.A. ADS's next earnings report?
Based on 2
analysts, Innate Pharma S.A. ADS is expected to report EPS of -$0.07 and revenue of $8.08M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement